Suspected non-Alzheimer disease pathophysiology - concept and controversy
Clifford R Jack, David S Knopman, Gael Chetelat, Dennis Dickson, Anne M Fagan, Giovanni B Frisoni, William Jagust, Elizabeth C Mormino, Ronald C Petersen, Reisa A Sperling, Wiesje M van der Flier, Victor L Villemagne, Pieter J Visser, Stephanie JB Vos
Nature Reviews Neurology | NATURE PUBLISHING GROUP | Published : 2016
Awarded by NIH
Awarded by Innovative Medicines Initiative Joint Undertaking under EMIF grant
C.R.J.Jr receives research funding from the NIH and the Alexander Family Alzheimer disease Disease Research Professorship of the Mayo Foundation. D.D. receives research support from the NIH (P50-AG016574; P50-NS072187; P01-AG003949) and CurePSP: Foundation for PSP/CBD and Related Disorders. A.M.F. receives research funding from the the DIAN Pharma Consortium and the Alzheimer disease Association. R.A.S. received research support from the BrightFocus Foundation. W.M.v.d.E receives research funding from the Netherlands Organization for Scientific Research (NWO), ZonMw, Cardiovasculair Onderzoek Nederland, and European Union (EU) 7" Framework Programme (FP7); all funds are paid to her institution. P.J.V. receives research funding from EU Joint Programme-Neurodegenerative Disease Research (JPND) and ZonMw, and from EU FP7 and Innovative Medicines Initiative joint resources, which are composed of financial contributions from EU FP7 (FP7/2007-2013) and in-kind contributions from the European Federation of Pharmaceutical Industries and Associations (EFPIA). S.J.B.V. receives research support from the Innovative Medicines Initiative Joint Undertaking under EMIF grant agreement no 115372, resources that are composed of financial contributions from EU FP7 (FP7/2007-2013) and in-kind contributions from EFPIA.